UCB builds on relationship with Microsoft with new AI deal; Sanofi partners with German AAV vector biotech
More biotechs are jumping on the AI bandwagon, and you can count UCB as one of them.
The Belgian company inked a “multi-year” deal with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
